Iowa Byetta Lawsuit

Iowa byetta lawsuit

The U.S. Food and Drug Administration (FDA) approved Byetta in 2005 to help type 2 diabetes patients better control their blood glucose levels. Although thousands of patients have used the medication to more effectively handle their conditions, others may consider filing an Iowa Byetta lawsuit if they believe that they suffered from severe, life-threatening injuries or complications as a result of the drug. Contact Attorney Group for Iowa today to determine whether you are entitled to pursue a claim against Amylin Pharmaceuticals in an Iowa Byetta lawsuit  and seek compensation for your condition.

Byetta Overview

Byetta and other similar medications work in the same manner as incretin. The drug helps to stimulate the patient’s pancreas to increase insulin production and help the patient to adjust his or her blood glucose levels as necessary. According to reports, Amylin Pharmaceuticals received $700 million in sales between the drug’s introduction in 2005 and 2008 despite the fact that several research studies established a potential link between Byetta and pancreatic cancer. Patients have also allegedly suffered from:

  • Abdominal and chest pain
  • Hypoglycemia
  • Immunogenicity
  • Renal impairment
  • Hypersensitivity
  • Acute necrotizing pancreatitis
  • Unstable blood pressure
  • Headaches, nausea, vomiting
  • Kidney failure or damage
  • Elevated heart and respiratory rates
  • Allergic reactions

In October 2007, the FDA released a public safety announcement to inform consumers of the risk of pancreatitis due to Byetta. According to the agency, 30 separate adverse event reports were submitted to the FDA, and the agency updated Byetta’s label in 2008 after receiving six more reports of necrotizing and pancreatitis as well as two fatalities.

Patients File Byetta Lawsuits

As a result of the potential link between the medication and pancreatitis, pancreatic cancer and other complications, patients across the U.S. have filed lawsuits against Amylin Pharmaceuticals to seek compensation for their injuries. According to court documents, plaintiffs allege that Amylin Pharmaceuticals had the legal and moral responsibility to warn the medical and public communities of the potential dangers of its product yet failed to do so for fear of losing profits. Additionally, Amylin is accused of neglecting to inform healthcare providers of the importance of routine testing and monitoring of their patients to identify any potential pancreatic changes that could indicate a more serious condition. According to plaintiffs, Amylin also neglected to adequately conduct research pertaining to the potential link between Byetta and health complications. Lawsuits assert that, had Amylin tested its product, the possible side effects and injuries could have potentially been caught and addressed before the medication was released for public use. If you believe that you have developed pancreatitis, pancreatic cancer or other condition as a result of your Byetta use, you may have a valid Iowa Byetta lawsuit. Consider seeking legal counsel as soon as possible to learn more about your legal rights and how to pursue a claim to seek compensation for your injuries.

Do You Have an Iowa Byetta Lawsuit? We Can Help

Contact Attorney Group for Iowa today to receive a free, comprehensive case evaluation to determine whether you are eligible to file an Iowa Byetta lawsuit. There is no cost to speak with us, and we can connect you with an affiliated attorney who can file your Iowa Byetta lawsuit and work to help you to recover the damages to which you may be entitled.